Sunshine Biopharma Inc. (SBFMW) — 10-Q Filings

10-Q Filings (6)

• Sunshine Biopharma's Losses Widen Despite Revenue Growth — Nov 13, 2025 Risk: high
  Sunshine Biopharma Inc. reported a net loss of $3,834,425 for the nine months ended September 30, 2025, an increase from a net loss of $2,975,904 in the same pe
• Sunshine Biopharma Remains Pre-Revenue, Navigates Capital Shifts — Aug 12, 2025 Risk: high
  Sunshine Biopharma Inc. reported no revenue for the three and six months ended June 30, 2025, and June 30, 2024, indicating a continued pre-revenue stage for th
• Sunshine Biopharma Files Q1 2025 10-Q — May 15, 2025 Risk: medium
  Sunshine Biopharma Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including b
• Sunshine Biopharma Files Q3 2024 10-Q — Nov 5, 2024 Risk: medium
  Sunshine Biopharma Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and provided updates on its business
• Sunshine Biopharma Files Q2 2024 10-Q — Aug 16, 2024 Risk: medium
  Sunshine Biopharma, Inc. filed its 10-Q for the period ending June 30, 2024. The company, previously known as Mountain West Business Solutions, Inc., is in the
• Sunshine Biopharma Files Q1 2024 10-Q — May 20, 2024 Risk: medium
  Sunshine Biopharma, Inc. filed its 10-Q for the period ending March 31, 2024. The company, previously known as Mountain West Business Solutions, Inc., is incorp

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX